Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 902-910
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.902
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.902
Figure 3 Treatment timeline of the patient.
mFOLFOX6: Oxaliplatin, leucovorin, and 5-FU; PFS: Progression-free survival; S1: Tegafur-gimeracil-oteracil potassium; XELOX: Oxaliplatin and capecitabine.
- Citation: Qu FJ, Wu S, Kong Y. Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report. World J Gastrointest Oncol 2023; 15(5): 902-910
- URL: https://www.wjgnet.com/1948-5204/full/v15/i5/902.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i5.902